nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylprednisolone—ABCB1—Dactinomycin—testicular cancer	0.109	0.193	CbGbCtD
Methylprednisolone—CYP3A4—Ifosfamide—testicular cancer	0.0773	0.137	CbGbCtD
Methylprednisolone—ABCB1—Vinblastine—testicular cancer	0.0684	0.121	CbGbCtD
Methylprednisolone—ABCB1—Cisplatin—testicular cancer	0.0628	0.111	CbGbCtD
Methylprednisolone—ABCB1—Etoposide—testicular cancer	0.0617	0.109	CbGbCtD
Methylprednisolone—ABCB1—Doxorubicin—testicular cancer	0.0421	0.0744	CbGbCtD
Methylprednisolone—CYP3A4—Vinblastine—testicular cancer	0.041	0.0725	CbGbCtD
Methylprednisolone—ABCB1—Methotrexate—testicular cancer	0.0407	0.0721	CbGbCtD
Methylprednisolone—CYP3A4—Etoposide—testicular cancer	0.0369	0.0654	CbGbCtD
Methylprednisolone—CYP3A4—Doxorubicin—testicular cancer	0.0252	0.0446	CbGbCtD
Methylprednisolone—Tachycardia—Cisplatin—testicular cancer	0.000453	0.00104	CcSEcCtD
Methylprednisolone—Asthenia—Bleomycin—testicular cancer	0.000452	0.00104	CcSEcCtD
Methylprednisolone—Convulsion—Etoposide—testicular cancer	0.000451	0.00104	CcSEcCtD
Methylprednisolone—Skin disorder—Cisplatin—testicular cancer	0.000451	0.00104	CcSEcCtD
Methylprednisolone—Hypertension—Etoposide—testicular cancer	0.000449	0.00103	CcSEcCtD
Methylprednisolone—Osteoarthritis—Doxorubicin—testicular cancer	0.000448	0.00103	CcSEcCtD
Methylprednisolone—Hyperhidrosis—Cisplatin—testicular cancer	0.000448	0.00103	CcSEcCtD
Methylprednisolone—Pruritus—Bleomycin—testicular cancer	0.000445	0.00102	CcSEcCtD
Methylprednisolone—Feeling abnormal—Ifosfamide—testicular cancer	0.000443	0.00102	CcSEcCtD
Methylprednisolone—Nausea—Vinblastine—testicular cancer	0.000443	0.00102	CcSEcCtD
Methylprednisolone—Affect lability—Doxorubicin—testicular cancer	0.000441	0.00102	CcSEcCtD
Methylprednisolone—Unspecified disorder of skin and subcutaneous tissue—Etoposide—testicular cancer	0.00044	0.00101	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Ifosfamide—testicular cancer	0.00044	0.00101	CcSEcCtD
Methylprednisolone—Pancreatitis—Methotrexate—testicular cancer	0.000439	0.00101	CcSEcCtD
Methylprednisolone—Discomfort—Etoposide—testicular cancer	0.000438	0.00101	CcSEcCtD
Methylprednisolone—Breast disorder—Epirubicin—testicular cancer	0.000438	0.00101	CcSEcCtD
Methylprednisolone—Hypotension—Cisplatin—testicular cancer	0.000433	0.000997	CcSEcCtD
Methylprednisolone—Hypersensitivity—Dactinomycin—testicular cancer	0.000433	0.000995	CcSEcCtD
Methylprednisolone—Confusional state—Etoposide—testicular cancer	0.000428	0.000986	CcSEcCtD
Methylprednisolone—Alanine aminotransferase increased—Epirubicin—testicular cancer	0.000427	0.000983	CcSEcCtD
Methylprednisolone—Muscular weakness—Epirubicin—testicular cancer	0.000427	0.000983	CcSEcCtD
Methylprednisolone—Urticaria—Ifosfamide—testicular cancer	0.000427	0.000983	CcSEcCtD
Methylprednisolone—Cardiac arrest—Doxorubicin—testicular cancer	0.000426	0.000981	CcSEcCtD
Methylprednisolone—Abdominal pain—Ifosfamide—testicular cancer	0.000425	0.000978	CcSEcCtD
Methylprednisolone—Anaphylactic shock—Etoposide—testicular cancer	0.000425	0.000977	CcSEcCtD
Methylprednisolone—Mood swings—Doxorubicin—testicular cancer	0.000425	0.000977	CcSEcCtD
Methylprednisolone—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.000423	0.000972	CcSEcCtD
Methylprednisolone—Infection—Etoposide—testicular cancer	0.000422	0.000971	CcSEcCtD
Methylprednisolone—Abdominal distension—Epirubicin—testicular cancer	0.000422	0.00097	CcSEcCtD
Methylprednisolone—Asthenia—Dactinomycin—testicular cancer	0.000421	0.000969	CcSEcCtD
Methylprednisolone—Paraesthesia—Cisplatin—testicular cancer	0.000416	0.000958	CcSEcCtD
Methylprednisolone—Tachycardia—Etoposide—testicular cancer	0.000415	0.000954	CcSEcCtD
Methylprednisolone—Skin disorder—Etoposide—testicular cancer	0.000413	0.000949	CcSEcCtD
Methylprednisolone—Hyperhidrosis—Etoposide—testicular cancer	0.000411	0.000945	CcSEcCtD
Methylprednisolone—Pancreatitis—Epirubicin—testicular cancer	0.000411	0.000945	CcSEcCtD
Methylprednisolone—Breast disorder—Doxorubicin—testicular cancer	0.000405	0.000932	CcSEcCtD
Methylprednisolone—Diarrhoea—Dactinomycin—testicular cancer	0.000402	0.000924	CcSEcCtD
Methylprednisolone—Vomiting—Bleomycin—testicular cancer	0.0004	0.000921	CcSEcCtD
Methylprednisolone—Infestation NOS—Methotrexate—testicular cancer	0.000399	0.000918	CcSEcCtD
Methylprednisolone—Infestation—Methotrexate—testicular cancer	0.000399	0.000918	CcSEcCtD
Methylprednisolone—Hypotension—Etoposide—testicular cancer	0.000397	0.000913	CcSEcCtD
Methylprednisolone—Rash—Bleomycin—testicular cancer	0.000397	0.000913	CcSEcCtD
Methylprednisolone—Dermatitis—Bleomycin—testicular cancer	0.000397	0.000912	CcSEcCtD
Methylprednisolone—Hypersensitivity—Ifosfamide—testicular cancer	0.000396	0.000912	CcSEcCtD
Methylprednisolone—Muscular weakness—Doxorubicin—testicular cancer	0.000395	0.00091	CcSEcCtD
Methylprednisolone—Alanine aminotransferase increased—Doxorubicin—testicular cancer	0.000395	0.00091	CcSEcCtD
Methylprednisolone—Abdominal distension—Doxorubicin—testicular cancer	0.00039	0.000897	CcSEcCtD
Methylprednisolone—Asthenia—Ifosfamide—testicular cancer	0.000386	0.000888	CcSEcCtD
Methylprednisolone—Sweating—Methotrexate—testicular cancer	0.000383	0.00088	CcSEcCtD
Methylprednisolone—Feeling abnormal—Cisplatin—testicular cancer	0.000382	0.000879	CcSEcCtD
Methylprednisolone—Paraesthesia—Etoposide—testicular cancer	0.000382	0.000878	CcSEcCtD
Methylprednisolone—Weight increased—Epirubicin—testicular cancer	0.000381	0.000877	CcSEcCtD
Methylprednisolone—Pruritus—Ifosfamide—testicular cancer	0.000381	0.000876	CcSEcCtD
Methylprednisolone—Pancreatitis—Doxorubicin—testicular cancer	0.00038	0.000874	CcSEcCtD
Methylprednisolone—Nausea—Bleomycin—testicular cancer	0.000374	0.00086	CcSEcCtD
Methylprednisolone—Infestation NOS—Epirubicin—testicular cancer	0.000373	0.000859	CcSEcCtD
Methylprednisolone—Infestation—Epirubicin—testicular cancer	0.000373	0.000859	CcSEcCtD
Methylprednisolone—Vomiting—Dactinomycin—testicular cancer	0.000373	0.000859	CcSEcCtD
Methylprednisolone—Rash—Dactinomycin—testicular cancer	0.00037	0.000851	CcSEcCtD
Methylprednisolone—Diarrhoea—Ifosfamide—testicular cancer	0.000368	0.000847	CcSEcCtD
Methylprednisolone—Fatigue—Etoposide—testicular cancer	0.000366	0.000843	CcSEcCtD
Methylprednisolone—Neuropathy peripheral—Epirubicin—testicular cancer	0.000366	0.000842	CcSEcCtD
Methylprednisolone—Haemoglobin—Methotrexate—testicular cancer	0.00036	0.000828	CcSEcCtD
Methylprednisolone—Haemorrhage—Methotrexate—testicular cancer	0.000358	0.000824	CcSEcCtD
Methylprednisolone—Sweating—Epirubicin—testicular cancer	0.000358	0.000824	CcSEcCtD
Methylprednisolone—Dizziness—Ifosfamide—testicular cancer	0.000356	0.000818	CcSEcCtD
Methylprednisolone—Weight increased—Doxorubicin—testicular cancer	0.000353	0.000811	CcSEcCtD
Methylprednisolone—Feeling abnormal—Etoposide—testicular cancer	0.00035	0.000805	CcSEcCtD
Methylprednisolone—Nausea—Dactinomycin—testicular cancer	0.000349	0.000802	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Etoposide—testicular cancer	0.000347	0.000799	CcSEcCtD
Methylprednisolone—Infestation NOS—Doxorubicin—testicular cancer	0.000346	0.000795	CcSEcCtD
Methylprednisolone—Infestation—Doxorubicin—testicular cancer	0.000346	0.000795	CcSEcCtD
Methylprednisolone—Visual impairment—Methotrexate—testicular cancer	0.000345	0.000794	CcSEcCtD
Methylprednisolone—Vomiting—Ifosfamide—testicular cancer	0.000342	0.000787	CcSEcCtD
Methylprednisolone—Hypersensitivity—Cisplatin—testicular cancer	0.000342	0.000786	CcSEcCtD
Methylprednisolone—Bradycardia—Epirubicin—testicular cancer	0.000341	0.000785	CcSEcCtD
Methylprednisolone—Rash—Ifosfamide—testicular cancer	0.000339	0.00078	CcSEcCtD
Methylprednisolone—Dermatitis—Ifosfamide—testicular cancer	0.000339	0.00078	CcSEcCtD
Methylprednisolone—Neuropathy peripheral—Doxorubicin—testicular cancer	0.000339	0.000779	CcSEcCtD
Methylprednisolone—Urticaria—Etoposide—testicular cancer	0.000338	0.000776	CcSEcCtD
Methylprednisolone—Haemoglobin—Epirubicin—testicular cancer	0.000337	0.000775	CcSEcCtD
Methylprednisolone—Rhinitis—Epirubicin—testicular cancer	0.000336	0.000773	CcSEcCtD
Methylprednisolone—Abdominal pain—Etoposide—testicular cancer	0.000336	0.000773	CcSEcCtD
Methylprednisolone—Haemorrhage—Epirubicin—testicular cancer	0.000335	0.000771	CcSEcCtD
Methylprednisolone—Eye disorder—Methotrexate—testicular cancer	0.000335	0.00077	CcSEcCtD
Methylprednisolone—Asthenia—Cisplatin—testicular cancer	0.000333	0.000765	CcSEcCtD
Methylprednisolone—Cardiac disorder—Methotrexate—testicular cancer	0.000332	0.000765	CcSEcCtD
Methylprednisolone—Sweating—Doxorubicin—testicular cancer	0.000331	0.000762	CcSEcCtD
Methylprednisolone—Connective tissue disorder—Epirubicin—testicular cancer	0.000329	0.000758	CcSEcCtD
Methylprednisolone—Angiopathy—Methotrexate—testicular cancer	0.000325	0.000748	CcSEcCtD
Methylprednisolone—Immune system disorder—Methotrexate—testicular cancer	0.000324	0.000744	CcSEcCtD
Methylprednisolone—Visual impairment—Epirubicin—testicular cancer	0.000323	0.000743	CcSEcCtD
Methylprednisolone—Mediastinal disorder—Methotrexate—testicular cancer	0.000323	0.000743	CcSEcCtD
Methylprednisolone—Nausea—Ifosfamide—testicular cancer	0.00032	0.000735	CcSEcCtD
Methylprednisolone—Diarrhoea—Cisplatin—testicular cancer	0.000317	0.00073	CcSEcCtD
Methylprednisolone—Bradycardia—Doxorubicin—testicular cancer	0.000316	0.000726	CcSEcCtD
Methylprednisolone—Mental disorder—Methotrexate—testicular cancer	0.000314	0.000722	CcSEcCtD
Methylprednisolone—Eye disorder—Epirubicin—testicular cancer	0.000313	0.000721	CcSEcCtD
Methylprednisolone—Hypersensitivity—Etoposide—testicular cancer	0.000313	0.00072	CcSEcCtD
Methylprednisolone—Malnutrition—Methotrexate—testicular cancer	0.000312	0.000717	CcSEcCtD
Methylprednisolone—Erythema—Methotrexate—testicular cancer	0.000312	0.000717	CcSEcCtD
Methylprednisolone—Haemoglobin—Doxorubicin—testicular cancer	0.000312	0.000717	CcSEcCtD
Methylprednisolone—Cardiac disorder—Epirubicin—testicular cancer	0.000311	0.000716	CcSEcCtD
Methylprednisolone—Rhinitis—Doxorubicin—testicular cancer	0.000311	0.000715	CcSEcCtD
Methylprednisolone—Haemorrhage—Doxorubicin—testicular cancer	0.00031	0.000714	CcSEcCtD
Methylprednisolone—Asthenia—Etoposide—testicular cancer	0.000305	0.000701	CcSEcCtD
Methylprednisolone—Connective tissue disorder—Doxorubicin—testicular cancer	0.000305	0.000701	CcSEcCtD
Methylprednisolone—Angiopathy—Epirubicin—testicular cancer	0.000304	0.0007	CcSEcCtD
Methylprednisolone—Immune system disorder—Epirubicin—testicular cancer	0.000303	0.000697	CcSEcCtD
Methylprednisolone—Mediastinal disorder—Epirubicin—testicular cancer	0.000302	0.000695	CcSEcCtD
Methylprednisolone—Pruritus—Etoposide—testicular cancer	0.000301	0.000692	CcSEcCtD
Methylprednisolone—Arrhythmia—Epirubicin—testicular cancer	0.000299	0.000689	CcSEcCtD
Methylprednisolone—Visual impairment—Doxorubicin—testicular cancer	0.000299	0.000688	CcSEcCtD
Methylprednisolone—Vomiting—Cisplatin—testicular cancer	0.000295	0.000678	CcSEcCtD
Methylprednisolone—Mental disorder—Epirubicin—testicular cancer	0.000294	0.000676	CcSEcCtD
Methylprednisolone—Rash—Cisplatin—testicular cancer	0.000292	0.000673	CcSEcCtD
Methylprednisolone—Dermatitis—Cisplatin—testicular cancer	0.000292	0.000672	CcSEcCtD
Methylprednisolone—Malnutrition—Epirubicin—testicular cancer	0.000292	0.000671	CcSEcCtD
Methylprednisolone—Erythema—Epirubicin—testicular cancer	0.000292	0.000671	CcSEcCtD
Methylprednisolone—Diarrhoea—Etoposide—testicular cancer	0.000291	0.000669	CcSEcCtD
Methylprednisolone—Eye disorder—Doxorubicin—testicular cancer	0.00029	0.000667	CcSEcCtD
Methylprednisolone—Ill-defined disorder—Methotrexate—testicular cancer	0.000289	0.000666	CcSEcCtD
Methylprednisolone—Cardiac disorder—Doxorubicin—testicular cancer	0.000288	0.000662	CcSEcCtD
Methylprednisolone—Angiopathy—Doxorubicin—testicular cancer	0.000281	0.000647	CcSEcCtD
Methylprednisolone—Malaise—Methotrexate—testicular cancer	0.000281	0.000647	CcSEcCtD
Methylprednisolone—Dizziness—Etoposide—testicular cancer	0.000281	0.000646	CcSEcCtD
Methylprednisolone—Immune system disorder—Doxorubicin—testicular cancer	0.00028	0.000645	CcSEcCtD
Methylprednisolone—Vertigo—Methotrexate—testicular cancer	0.00028	0.000644	CcSEcCtD
Methylprednisolone—Mediastinal disorder—Doxorubicin—testicular cancer	0.00028	0.000643	CcSEcCtD
Methylprednisolone—Arrhythmia—Doxorubicin—testicular cancer	0.000277	0.000637	CcSEcCtD
Methylprednisolone—Nausea—Cisplatin—testicular cancer	0.000275	0.000634	CcSEcCtD
Methylprednisolone—Mental disorder—Doxorubicin—testicular cancer	0.000272	0.000625	CcSEcCtD
Methylprednisolone—Ill-defined disorder—Epirubicin—testicular cancer	0.000271	0.000623	CcSEcCtD
Methylprednisolone—Convulsion—Methotrexate—testicular cancer	0.00027	0.000622	CcSEcCtD
Methylprednisolone—Vomiting—Etoposide—testicular cancer	0.00027	0.000621	CcSEcCtD
Methylprednisolone—Erythema—Doxorubicin—testicular cancer	0.00027	0.000621	CcSEcCtD
Methylprednisolone—Malnutrition—Doxorubicin—testicular cancer	0.00027	0.000621	CcSEcCtD
Methylprednisolone—Rash—Etoposide—testicular cancer	0.000268	0.000616	CcSEcCtD
Methylprednisolone—Dermatitis—Etoposide—testicular cancer	0.000268	0.000616	CcSEcCtD
Methylprednisolone—Headache—Etoposide—testicular cancer	0.000266	0.000612	CcSEcCtD
Methylprednisolone—Arthralgia—Methotrexate—testicular cancer	0.000265	0.000611	CcSEcCtD
Methylprednisolone—Myalgia—Methotrexate—testicular cancer	0.000265	0.000611	CcSEcCtD
Methylprednisolone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000264	0.000607	CcSEcCtD
Methylprednisolone—Malaise—Epirubicin—testicular cancer	0.000263	0.000605	CcSEcCtD
Methylprednisolone—Discomfort—Methotrexate—testicular cancer	0.000262	0.000603	CcSEcCtD
Methylprednisolone—Vertigo—Epirubicin—testicular cancer	0.000262	0.000603	CcSEcCtD
Methylprednisolone—Syncope—Epirubicin—testicular cancer	0.000262	0.000602	CcSEcCtD
Methylprednisolone—Confusional state—Methotrexate—testicular cancer	0.000257	0.00059	CcSEcCtD
Methylprednisolone—Loss of consciousness—Epirubicin—testicular cancer	0.000257	0.00059	CcSEcCtD
Methylprednisolone—Anaphylactic shock—Methotrexate—testicular cancer	0.000255	0.000585	CcSEcCtD
Methylprednisolone—Convulsion—Epirubicin—testicular cancer	0.000253	0.000582	CcSEcCtD
Methylprednisolone—Infection—Methotrexate—testicular cancer	0.000253	0.000582	CcSEcCtD
Methylprednisolone—Nausea—Etoposide—testicular cancer	0.000252	0.000581	CcSEcCtD
Methylprednisolone—Hypertension—Epirubicin—testicular cancer	0.000252	0.00058	CcSEcCtD
Methylprednisolone—Ill-defined disorder—Doxorubicin—testicular cancer	0.000251	0.000576	CcSEcCtD
Methylprednisolone—Nervous system disorder—Methotrexate—testicular cancer	0.00025	0.000574	CcSEcCtD
Methylprednisolone—Myalgia—Epirubicin—testicular cancer	0.000248	0.000572	CcSEcCtD
Methylprednisolone—Arthralgia—Epirubicin—testicular cancer	0.000248	0.000572	CcSEcCtD
Methylprednisolone—Anxiety—Epirubicin—testicular cancer	0.000248	0.00057	CcSEcCtD
Methylprednisolone—Skin disorder—Methotrexate—testicular cancer	0.000247	0.000569	CcSEcCtD
Methylprednisolone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000247	0.000568	CcSEcCtD
Methylprednisolone—Hyperhidrosis—Methotrexate—testicular cancer	0.000246	0.000566	CcSEcCtD
Methylprednisolone—Discomfort—Epirubicin—testicular cancer	0.000245	0.000565	CcSEcCtD
Methylprednisolone—Malaise—Doxorubicin—testicular cancer	0.000244	0.00056	CcSEcCtD
Methylprednisolone—Vertigo—Doxorubicin—testicular cancer	0.000243	0.000558	CcSEcCtD
Methylprednisolone—Syncope—Doxorubicin—testicular cancer	0.000242	0.000557	CcSEcCtD
Methylprednisolone—Confusional state—Epirubicin—testicular cancer	0.00024	0.000552	CcSEcCtD
Methylprednisolone—Anaphylactic shock—Epirubicin—testicular cancer	0.000238	0.000548	CcSEcCtD
Methylprednisolone—Hypotension—Methotrexate—testicular cancer	0.000238	0.000547	CcSEcCtD
Methylprednisolone—Loss of consciousness—Doxorubicin—testicular cancer	0.000237	0.000546	CcSEcCtD
Methylprednisolone—Infection—Epirubicin—testicular cancer	0.000237	0.000544	CcSEcCtD
Methylprednisolone—Shock—Epirubicin—testicular cancer	0.000234	0.000539	CcSEcCtD
Methylprednisolone—Convulsion—Doxorubicin—testicular cancer	0.000234	0.000538	CcSEcCtD
Methylprednisolone—Nervous system disorder—Epirubicin—testicular cancer	0.000234	0.000537	CcSEcCtD
Methylprednisolone—Hypertension—Doxorubicin—testicular cancer	0.000233	0.000536	CcSEcCtD
Methylprednisolone—Tachycardia—Epirubicin—testicular cancer	0.000232	0.000535	CcSEcCtD
Methylprednisolone—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000232	0.000533	CcSEcCtD
Methylprednisolone—Skin disorder—Epirubicin—testicular cancer	0.000231	0.000532	CcSEcCtD
Methylprednisolone—Hyperhidrosis—Epirubicin—testicular cancer	0.00023	0.00053	CcSEcCtD
Methylprednisolone—Insomnia—Methotrexate—testicular cancer	0.00023	0.00053	CcSEcCtD
Methylprednisolone—Arthralgia—Doxorubicin—testicular cancer	0.00023	0.000529	CcSEcCtD
Methylprednisolone—Myalgia—Doxorubicin—testicular cancer	0.00023	0.000529	CcSEcCtD
Methylprednisolone—Anxiety—Doxorubicin—testicular cancer	0.000229	0.000527	CcSEcCtD
Methylprednisolone—Paraesthesia—Methotrexate—testicular cancer	0.000229	0.000526	CcSEcCtD
Methylprednisolone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000228	0.000525	CcSEcCtD
Methylprednisolone—Discomfort—Doxorubicin—testicular cancer	0.000227	0.000522	CcSEcCtD
Methylprednisolone—Dyspepsia—Methotrexate—testicular cancer	0.000224	0.000515	CcSEcCtD
Methylprednisolone—Hypotension—Epirubicin—testicular cancer	0.000223	0.000512	CcSEcCtD
Methylprednisolone—Confusional state—Doxorubicin—testicular cancer	0.000222	0.000511	CcSEcCtD
Methylprednisolone—Anaphylactic shock—Doxorubicin—testicular cancer	0.00022	0.000507	CcSEcCtD
Methylprednisolone—Fatigue—Methotrexate—testicular cancer	0.000219	0.000505	CcSEcCtD
Methylprednisolone—Infection—Doxorubicin—testicular cancer	0.000219	0.000504	CcSEcCtD
Methylprednisolone—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000217	0.000499	CcSEcCtD
Methylprednisolone—Shock—Doxorubicin—testicular cancer	0.000217	0.000499	CcSEcCtD
Methylprednisolone—Nervous system disorder—Doxorubicin—testicular cancer	0.000216	0.000497	CcSEcCtD
Methylprednisolone—Insomnia—Epirubicin—testicular cancer	0.000215	0.000496	CcSEcCtD
Methylprednisolone—Tachycardia—Doxorubicin—testicular cancer	0.000215	0.000495	CcSEcCtD
Methylprednisolone—Skin disorder—Doxorubicin—testicular cancer	0.000214	0.000492	CcSEcCtD
Methylprednisolone—Paraesthesia—Epirubicin—testicular cancer	0.000214	0.000492	CcSEcCtD
Methylprednisolone—Hyperhidrosis—Doxorubicin—testicular cancer	0.000213	0.00049	CcSEcCtD
Methylprednisolone—Feeling abnormal—Methotrexate—testicular cancer	0.00021	0.000482	CcSEcCtD
Methylprednisolone—Dyspepsia—Epirubicin—testicular cancer	0.00021	0.000482	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Methotrexate—testicular cancer	0.000208	0.000479	CcSEcCtD
Methylprednisolone—Hypotension—Doxorubicin—testicular cancer	0.000206	0.000474	CcSEcCtD
Methylprednisolone—Fatigue—Epirubicin—testicular cancer	0.000205	0.000472	CcSEcCtD
Methylprednisolone—Urticaria—Methotrexate—testicular cancer	0.000202	0.000465	CcSEcCtD
Methylprednisolone—Abdominal pain—Methotrexate—testicular cancer	0.000201	0.000463	CcSEcCtD
Methylprednisolone—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000201	0.000462	CcSEcCtD
Methylprednisolone—Insomnia—Doxorubicin—testicular cancer	0.000199	0.000459	CcSEcCtD
Methylprednisolone—Paraesthesia—Doxorubicin—testicular cancer	0.000198	0.000455	CcSEcCtD
Methylprednisolone—Feeling abnormal—Epirubicin—testicular cancer	0.000196	0.000451	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Epirubicin—testicular cancer	0.000195	0.000448	CcSEcCtD
Methylprednisolone—Dyspepsia—Doxorubicin—testicular cancer	0.000194	0.000446	CcSEcCtD
Methylprednisolone—Fatigue—Doxorubicin—testicular cancer	0.00019	0.000437	CcSEcCtD
Methylprednisolone—Urticaria—Epirubicin—testicular cancer	0.000189	0.000435	CcSEcCtD
Methylprednisolone—Abdominal pain—Epirubicin—testicular cancer	0.000188	0.000433	CcSEcCtD
Methylprednisolone—Hypersensitivity—Methotrexate—testicular cancer	0.000188	0.000431	CcSEcCtD
Methylprednisolone—Asthenia—Methotrexate—testicular cancer	0.000183	0.00042	CcSEcCtD
Methylprednisolone—Feeling abnormal—Doxorubicin—testicular cancer	0.000182	0.000418	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Doxorubicin—testicular cancer	0.00018	0.000415	CcSEcCtD
Methylprednisolone—Pruritus—Methotrexate—testicular cancer	0.00018	0.000414	CcSEcCtD
Methylprednisolone—Hypersensitivity—Epirubicin—testicular cancer	0.000175	0.000404	CcSEcCtD
Methylprednisolone—Urticaria—Doxorubicin—testicular cancer	0.000175	0.000403	CcSEcCtD
Methylprednisolone—Abdominal pain—Doxorubicin—testicular cancer	0.000174	0.000401	CcSEcCtD
Methylprednisolone—Diarrhoea—Methotrexate—testicular cancer	0.000174	0.000401	CcSEcCtD
Methylprednisolone—Asthenia—Epirubicin—testicular cancer	0.000171	0.000393	CcSEcCtD
Methylprednisolone—Pruritus—Epirubicin—testicular cancer	0.000169	0.000388	CcSEcCtD
Methylprednisolone—Dizziness—Methotrexate—testicular cancer	0.000168	0.000387	CcSEcCtD
Methylprednisolone—Diarrhoea—Epirubicin—testicular cancer	0.000163	0.000375	CcSEcCtD
Methylprednisolone—Hypersensitivity—Doxorubicin—testicular cancer	0.000162	0.000373	CcSEcCtD
Methylprednisolone—Vomiting—Methotrexate—testicular cancer	0.000162	0.000372	CcSEcCtD
Methylprednisolone—Rash—Methotrexate—testicular cancer	0.00016	0.000369	CcSEcCtD
Methylprednisolone—Dermatitis—Methotrexate—testicular cancer	0.00016	0.000369	CcSEcCtD
Methylprednisolone—Headache—Methotrexate—testicular cancer	0.000159	0.000367	CcSEcCtD
Methylprednisolone—Asthenia—Doxorubicin—testicular cancer	0.000158	0.000364	CcSEcCtD
Methylprednisolone—Dizziness—Epirubicin—testicular cancer	0.000158	0.000362	CcSEcCtD
Methylprednisolone—Pruritus—Doxorubicin—testicular cancer	0.000156	0.000359	CcSEcCtD
Methylprednisolone—Vomiting—Epirubicin—testicular cancer	0.000151	0.000348	CcSEcCtD
Methylprednisolone—Nausea—Methotrexate—testicular cancer	0.000151	0.000348	CcSEcCtD
Methylprednisolone—Diarrhoea—Doxorubicin—testicular cancer	0.000151	0.000347	CcSEcCtD
Methylprednisolone—Rash—Epirubicin—testicular cancer	0.00015	0.000345	CcSEcCtD
Methylprednisolone—Dermatitis—Epirubicin—testicular cancer	0.00015	0.000345	CcSEcCtD
Methylprednisolone—Headache—Epirubicin—testicular cancer	0.000149	0.000343	CcSEcCtD
Methylprednisolone—Dizziness—Doxorubicin—testicular cancer	0.000146	0.000335	CcSEcCtD
Methylprednisolone—Nausea—Epirubicin—testicular cancer	0.000141	0.000325	CcSEcCtD
Methylprednisolone—Vomiting—Doxorubicin—testicular cancer	0.00014	0.000322	CcSEcCtD
Methylprednisolone—Rash—Doxorubicin—testicular cancer	0.000139	0.00032	CcSEcCtD
Methylprednisolone—Dermatitis—Doxorubicin—testicular cancer	0.000139	0.000319	CcSEcCtD
Methylprednisolone—Headache—Doxorubicin—testicular cancer	0.000138	0.000318	CcSEcCtD
Methylprednisolone—Nausea—Doxorubicin—testicular cancer	0.000131	0.000301	CcSEcCtD
